Comparative study between sugammedex and neostigmine as a reversal agent of rocuronium for pediatric patients 2-12 years old going for surgery under general anaesthesia

Автор: Abed H.E.A., Abdelaziz A.M.R.

Статья в выпуске: 27, 2023 года.

Бесплатный доступ

Aim. The neuromuscular blocker has long been used during surgical procedures. The neuromuscular blockade produced by rocuronium can be reversed with sugammadex and neostigmine as reversal agents. This systematic review aims to determine the impact of sugammadex and neostigmine comparison as a reversal agent of rocuronium for pediatric patients 2-12 years old going for surgery under general anesthesia. Materials and Methods. This review examined recent studies assessing the impact of sugammadex and neostigmine comparison as a reversal agent of rocuronium for pediatric patients 2-12 years old going for surgery under general anesthesia. Data were searched from Google Scholar, PubMed, Hindawi, Anesthesiology, MEDLINE, and CENTRAL using keywords’ General Anesthesia,’ ‘Reversal Agent,’ ‘Rocuronium for Pediatric Patients,’ ‘Neuromuscular Blockers,’ ‘Sugammadex and Neostigmine,’ ‘Role of Analgesics.’ The review followed PRISMA guidelines. Results. The initial search for publications comparing sugammadex and neostigmine as a reversal agent of rocuronium for pediatric patients yielded 9000 papers, from which 600 were selected. The reviews’ articles were further analyzed to ensure they were pertinent to the Comparative Impact of Reversal Agents (Sugammadex And Neostigmine) of Rocuronium for Pediatric Patients. Around 319 references were examined for their potential applicability to the medical field of anesthesia. A total of 15 articles were included, with preference given to those published from 2014 to 2023 during the last ten years. Conclusion. The particular relaxant-binding medication promptly and successfully alleviates rocuronium-induced neuromuscular blockade in pediatric surgery patients. Considering the study’s outcomes, it can be concluded that sugammadex may restore any level of steroidal muscle relaxant-induced neuromuscular block faster than neostigmine.

Еще

Analgesics, central nervous system, muscle relaxants, neuromuscular blockers, neostigmine, pediatric patients, pain, reversal agents, surgery, sugammadex

Короткий адрес: https://sciup.org/148326613

IDR: 148326613 | DOI: 10.18137/cardiometry.2023.27.181193

Список литературы Comparative study between sugammedex and neostigmine as a reversal agent of rocuronium for pediatric patients 2-12 years old going for surgery under general anaesthesia

Kehlet H, Dahl JB. Anaesthesia, surgery, and challenges in postoperative recovery. The Lancet. 2003; 362(9399):1921-8.
Tranquilli WJ, Grimm KA. Introduction: use, definitions, history, concepts, classification, and considerations for anesthesia and analgesia. Veterinary Anesthesia and Analgesia: The Fifth Edition of Lumb and Jones. 2015:1-10.
Heavner J. Veterinary anesthesia update. Journal of the American Veterinary Medical Association. 1983; 182(1):30-.
Winters W, Ferrar-Allado T, Guzman-Flores C, Alcaraz M. The cataleptic state induced by ketamine: a review of the neuropharmacology of anesthesia. Neuropharmacology. 1972;11(3):303-15.
Das S, Ghosh S. Monitored anesthesia care: An overview. Journal of anaesthesiology, clinical pharmacology. 2015;31(1):27.
Sadrolsadat SH, Mahdavi AR, Moharari RS, Khajavi MR, Khashayar P, Najafi A, et al. A prospective randomized trial comparing the technique of spinal and general anesthesia for lumbar disk surgery: a study of 100 cases. Surgical neurology. 2009;71(1):60-5.
Zafirova Z, Dalton A. Neuromuscular blockers and reversal agents and their impact on anesthesia practice. Best Practice & Research Clinical Anaesthesiology. 2018;32(2):203-11.
Naguib M, Magboul MM. Adverse effects of neuromuscular blockers and their antagonists. Drug safety. 1998;18:99-116.
Hall JB, Schweickert W, Kress JP. Role of analgesics, sedatives, neuromuscular blockers, and delirium. Critical care medicine. 2009;37(10):S416-S21.
Feldman S, Karalliedde L. Drug interactions with neuromuscular blockers. Drug safety. 1996; 15(4): 261-73.
Murphy GS, Szokol JW, Marymont JH, Greenberg SB, Avram MJ, Vender JS. Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesthesia & Analgesia. 2008; 107(1): 130-7.
Akha AS, Rosa J, Jahr JS, Li A, Kiai K. Sugammadex: cyclodextrins, development of selective binding agents, pharmacology, clinical development, and future directions. Anesthesiology clinics. 2010; 28(4): 691-708.
Khuenl-Brady KS, Wattwil M, Vanacker BF, Lora-Tamayo JI, Rietbergen H, Alvarez-Gómez JA. Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial. Anesthesia & Analgesia. 2010;110(1):64-73.
Schaller SJ, Fink H. Sugammadex as a reversal agent for neuromuscular block: an evidence-based review. Core evidence. 2013;8:57.
Renew JR, Brull SJ, Naguib M. Clinical pharmacology of drugs acting at the neuromuscular junction. Basic Sciences in Anesthesia. 2018:139-59.
Brueckmann B, Sasaki N, Grobara P, Li M, Woo T, de Bie J, et al. Effects of Sugammadex on Incidence of Postoperative Residual Neuromuscular Blockade: A Randomized, Controlled Study. Survey of Anesthesiology.2016;60(4):167-8.
Bom A, Hope F, Rutherford S, Thomson K. Preclinical pharmacology of sugammadex. Journal of critical care. 2009;24(1):29-35.
Abad‐Gurumeta A, Ripollés‐Melchor J, Casans‐ Francés R, Espinosa A, Martínez‐Hurtado E, Fernández‐ Pérez C, et al. A systematic review of sugammadex vs neostigmine for reversal of neuromuscular blockade. Anaesthesia. 2015; 70(12): 1441-52.
Hristovska AM, Duch P, Allingstrup M, Afshari A. The comparative efficacy and safety of sugammadex and neostigmine in reversing neuromuscular blockade in adults. A Cochrane systematic review with meta‐analysis and trial sequential analysis. Anaesthesia. 2018; 73(5):631-41.
Hristovska AM, Duch P, Allingstrup M, Afshari A, Group CA. Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults. Cochrane Database of Systematic Reviews. 1996; 2017(9).
Ghoneim AA, El Beltagy MA. Comparative study between sugammadex and neostigmine in neurosurgical anesthesia in pediatric patients. Saudi Journal of Anaesthesia. 2015;9(3):247.
Cammu G, Van Vlem B, Van Den Heuvel M, Stet L, el Galta R, Eloot S, et al. Dialysability of sugammadex and its complex with rocuronium in intensive care patients with severe renal impairment. British journal of anaesthesia. 2012;109(3):382-90.
Meretoja OA. Neuromuscular block and current treatment strategies for its reversal in children. Pediatric Anesthesia. 2010;20(7):591-604.
Ammar A, Mahmoud K, Kasemy Z. A comparison of sugammadex and neostigmine for reversal of rocuronium‐ induced neuromuscular blockade in children. Acta Anaesthesiologica Scandinavica. 2017; 61(4): 374-80.
Liu G, Wang R, Yan Y, Fan L, Xue J, Wang T. The efficacy and safety of sugammadex for reversing postoperative residual neuromuscular blockade in pediatric patients: A systematic review. Scientific reports. 2017; 7(1):5724.
Tobias JD. Current evidence for the use of sugammadex in children. Pediatric Anesthesia. 2017; 27(2): 118-25.
Plaud B, Meretoja O, Hofmockel R, Raft J, Stoddart PA, Van Kuijk JH, et al. Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients. The Journal of the American Society of Anesthesiologists. 2009; 110(2): 284-94.
Gaver RS, Brenn BR, Gartley A, Donahue BS. Retrospective analysis of the safety and efficacy of sugammadex versus neostigmine for the reversal of neuromuscular blockade in children. Anesthesia & Analgesia. 2019; 129(4): 1124-9.
Kara T, Ozbagriacik O, Turk HS, Isil CT, Gokuc O, Unsal O, et al. Sugammadex versus neostigmine in pediatric patients: a prospective randomized study. Revista Brasileira de Anestesiologia. 2014; 64: 400-5.
Won YJ, Lim BG, Lee DK, Kim H, Kong MH, Lee IO. Sugammadex for reversal of rocuronium-induced neuromuscular blockade in pediatric patients: a systematic review and meta-analysis. Medicine. 2016; 95(34).
Lang B, Han L, Zeng L, Zhang Q, Chen S, Huang L, et al. Efficacy and safety of sugammadex for neuromuscular blockade reversal in pediatric patients: an updated meta-analysis of randomized controlled trials with trial sequential analysis. BMC pediatrics. 2022; 22(1): 1-12.
Fabregat-López J, Veiga-Ruiz G, Dominguez-Serrano N, García-Martinez MR. Re-establishment of neuromuscular block by rocuronium after sugammadex administration. Canadian Journal of Anesthesia/Journal canadien d’anesthésie. 2011;58:658-9.
Cammu G, de Kam PJ, De Graeve K, van den Heuvel M, Suy K, Morias K, et al. Repeat dosing of rocuronium 1.2 mg kg-1 after reversal of neuromuscular block by sugammadex 4.0 mg kg-1 in anaesthetized healthy volunteers: a modelling-based pilot study. Br J Anaesth. 2010;105(4):487-92.
Pani N, Dongare PA, Mishra RK. Reversal agents in anaesthesia and critical care. Indian J Anaesth. 2015; 59(10): 664-9.
Li L, Jiang Y, Zhang W. Sugammadex for Fast- Track Surgery in Children Undergoing Cardiac Surgery: A Randomized Controlled Study. J Cardiothorac Vasc Anesth. 2021; 35(5): 1388-92.
Voss T, Wang A, DeAngelis M, Speek M, Saldien V, Hammer GB, et al. Sugammadex for reversal of neuromuscular blockade in pediatric patients: Results from a phase IV randomized study. Paediatr Anaesth. 2022; 32(3): 436-45.
Herring WJ, Woo T, Assaid CA, Lupinacci RJ, Lemmens HJ, Blobner M, et al. Sugammadex efficacy for reversal of rocuronium- and vecuronium-induced neuromuscular blockade: A pooled analysis of 26 studies. J Clin Anesth. 2017;41:84-91.
An J, Lee JH, Kim E, Woo K, Kim H, Lee D. Comparison of sugammadex and pyridostigmine bromide for reversal of rocuronium-induced neuromuscular blockade in short-term pediatric surgery: A prospective randomized study. Medicine (Baltimore). 2020; 99(7): e19130.
Xiaobing L, Yan J, Wangping Z, Rufang Z, Jia L, Rong W. Effects of sugammadex on postoperative respiratory management in children with congenital heart disease: a randomized controlled study. Biomed Pharmacother. 2020; 127:110180.
Matsui M, Konishi J, Suzuki T, Sekijima C, Miyazawa N, Yamamoto S. Reversibility of Rocuronium- Induced Deep Neuromuscular Block with Sugammadex in Infants and Children-A Randomized Study. Biol Pharm Bull. 2019; 42(10):1637-40.
Gulec E, Biricik E, Turktan M, Hatipoglu Z, Unlugenc H. The effect of intravenous dexamethasone on sugammadex reversal time in children undergoing adenotonsillectomy. Anesthesia & Analgesia. 2016; 122(4): 1147-52.
Arends J, Hubbard R, Shafy SZ, Hakim M, Kim SS, Tumin D, et al. Heart Rate Changes Following the Administration of Sugammadex to Infants and Children With Comorbid Cardiac, Cardiovascular, and Congenital Heart Diseases. Cardiol Res. 2020;11(5):274-9.
Gaver RS, Brenn BR, Gartley A, Donahue BS. Retrospective Analysis of the Safety and Efficacy of Sugammadex Versus Neostigmine for the Reversal of Neuromuscular Blockade in Children. Anesth Analg. 2019; 129(4):1124-9.
Alonso A, De Boer H, Booij L. Reversal of rocuronium- induced neuromuscular block by sugammadex in neonates: 10AP1-3. European Journal of Anaesthesiology| EJA. 2014; 31:163.
Ji SH, Huh KY, Oh J, Jeong HJ, Jang YE, Kim EH, et al. Reversal of rocuronium‐induced intense neuromuscular blockade by sugammadex in Korean children: A pharmacokinetic and pharmacodynamic analysis. Clinical and Translational Science. 2023; 16(1):92-103.
Schaller SJ, Lewald H. Clinical pharmacology and efficacy of sugammadex in the reversal of neuromuscular blockade. Expert Opinion on Drug Metabolism & Toxicology. 2016; 12(9): 1097-108.

Еще

Статья научная